Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Allergy & Immunology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Safe and Effective Drug Provocation Tests in Mastocytosis
November 2025
Discover a study on drug provocation tests in mastocytosis, revealing how they safely identify tolerable medications and reduce the risk of severe hypersensitivity reactions.
Read more
4 Nov 2025
Safe and Effective Drug Provocation Tests in Mastocytosis
Discover a study on drug provocation tests in mastocytosis, revealing how they safely identify tolerable medications and reduce the risk of severe hypersensitivity reactions.
2 Nov 2025
Peanut Sublingual Immunotherapy Shows Long-Term Benefits
A recent study examined 36 months of peanut sublingual immunotherapy in children aged 1–4 years, assessing both desensitisation and remission outcomes.
31 Oct 2025
High TSLP and Its Impact on Adult Asthma
Patients with elevated TSLP may represent a unique target population for specific therapies, including biologics that modulate Type 2 inflammation.
29 Oct 2025
Allergic Rhinitis Phenotypes in Children: New Insights
The JECS cohort followed more than 88,000 newborns across Japan, assessing allergic conditions from birth to age four.
27 Oct 2025
Early Food Introduction Reduces Paediatric Food Allergy
These declines were observed regardless of atopic dermatitis diagnosis, indicating that early food introduction benefits both high-risk and general populations.
25 Oct 2025
Glucocorticoid-Mediated Eosinopoiesis in Asthma Explained
This paradoxical effect appears to be context-dependent, influenced by factors such as infection, allergen exposure, and systemic stress.
21 Oct 2025
New Insights into Asthma: Pseudo Leukotrienes and Inflammation
The study found that urinary øLT levels were significantly elevated, four- to five-fold higher, in patients with severe asthma compared to healthy controls.
19 Oct 2025
Enhancing PPIE in Allergy Research and Practice
Enhancing PPIE in allergic disease research offers tangible benefits, from improving patient outcomes to ensuring studies align with real-world needs.
Loading posts...
1
2
3
…
37
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View